Deutsche Bank Aktiengesellschaft Downgrades Amedisys (NASDAQ:AMED) to Hold

Deutsche Bank Aktiengesellschaft lowered shares of Amedisys (NASDAQ:AMED) from a buy rating to a hold rating in a research report sent to investors on Monday morning, Marketbeat Ratings reports. They currently have $101.00 price objective on the health services provider’s stock.

A number of other equities analysts also recently commented on AMED. Cantor Fitzgerald reaffirmed a neutral rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. StockNews.com raised shares of Amedisys from a hold rating to a buy rating in a research report on Saturday, May 4th. Finally, William Blair cut shares of Amedisys from an outperform rating to a market perform rating in a report on Monday, July 1st. Four analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Amedisys has a consensus rating of Hold and a consensus price target of $100.67.

Amedisys Stock Performance

NASDAQ:AMED opened at $98.08 on Monday. The firm has a 50-day moving average of $95.03 and a two-hundred day moving average of $93.93. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market cap of $3.20 billion, a P/E ratio of -153.25, a PEG ratio of 1.94 and a beta of 0.79. Amedisys has a 1-year low of $89.55 and a 1-year high of $98.95.

Hedge Funds Weigh In On Amedisys

Several institutional investors and hedge funds have recently added to or reduced their stakes in AMED. Retirement Systems of Alabama increased its stake in Amedisys by 0.3% in the 4th quarter. Retirement Systems of Alabama now owns 40,871 shares of the health services provider’s stock valued at $3,885,000 after buying an additional 125 shares during the period. Treasurer of the State of North Carolina grew its holdings in shares of Amedisys by 1.0% during the 4th quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock valued at $1,350,000 after acquiring an additional 140 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in shares of Amedisys by 2.2% in the first quarter. Louisiana State Employees Retirement System now owns 9,400 shares of the health services provider’s stock worth $866,000 after acquiring an additional 200 shares during the last quarter. Bridge City Capital LLC raised its holdings in shares of Amedisys by 0.8% during the first quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider’s stock worth $2,752,000 after acquiring an additional 231 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in Amedisys by 0.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider’s stock valued at $2,876,000 after purchasing an additional 255 shares during the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.